LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2025 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2025 Earnings Call Transcript May 1, 2025LeMaitre Vascular, Inc. misses on earnings expectations.
Posts Tagged ‘NASDAQ:LMAT’
Jim Cramer Recently Talked About These 15 Stocks
On Tuesday, Jim Cramer, host of Mad Money, offered his perspective on the day’s market rally as he delved into the impact of the ongoing dynamic between President Donald Trump...
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2024 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2024 Earnings Call Transcript February 27, 2025LeMaitre Vascular, Inc. reports earnings inline with expectations.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2024 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2024 Earnings Call Transcript October 31, 2024LeMaitre Vascular, Inc. beats earnings expectations.
LeMaitre Vascular (LMAT) Surged Due to Robust Global Markets
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Small Cap Fund” second quarter 2024 investor letter.
Robust Quarterly Result Lifted LeMaitre Vascular (LMAT) in Q2
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2024 investor letter.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2024 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2024 Earnings Call Transcript August 1, 2024LeMaitre Vascular, Inc. beats earnings expectations.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call Transcript
Operator: Good day ladies and gentlemen. Welcome to the LeMaitre Vascular First Quarter 2024 Financial Results Conference Call.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.38, expectations were $0.36. LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2023 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q3 2023 Financial Results Conference Call. After the speaker’s presentation, there will be a question-and-answer session.
Here’s Why LeMaitre Vascular (LMAT) Outperformed in Q2
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2023 investor letter.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2023 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q2 2023 Financial Results Conference Call. As a reminder, today’s call is being recorded.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2023 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q1 2023 Financial Results Conference Call. As a reminder, today's call is being recorded.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2022 Earnings Call Transcript
Operator: Welcome to LeMaitre Vascular Q4 2022 Financial Results Conference Call. As a reminder, today's call is being recorded.
Where Do Hedge Funds Stand On LeMaitre Vascular Inc (LMAT)?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is LMAT A Good Stock To Buy Now?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money ...
Should You Be Tempted To ‘Sell’ LeMaitre Vascular (LMAT) Stock
Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. During the third quarter of 2020, the Polen U.S.
Hedge Fund and Insider Trading News: Daniel Loeb, Bill Ackman, Crispin Odey, Warren Buffett, Steve Cohen, LeMaitre Vascular Inc (LMAT), and More
Longtime hedge fund manager and activist investor Daniel Loeb, manager of Third Point, continued to bet on e-commerce companies in the second quarter, as well as a few retailers...
LeMaitre Vascular Inc (LMAT): Hedge Funds Are Turning Bearish
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Is LeMaitre Vascular Inc (LMAT) A Good Stock To Buy?
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Did Hedge Funds Drop The Ball On LeMaitre Vascular Inc (LMAT) ?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Is LeMaitre Vascular Inc (LMAT) A Good Stock To Buy?
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is LeMaitre Vascular Inc (LMAT) A Good Stock To Buy?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the ...
Top 75 Healthcare Dividend Stocks To Invest In
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
How LeMaitre Vascular Inc (LMAT) Stacks Up Against Its Peers
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Hedge Funds Are Buying LeMaitre Vascular Inc (LMAT)
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment firms that we track ...
LeMaitre Vascular Inc (LMAT), Boston Scientific Corporation (BSX) – The Race In Medical Device Industry: Who Is The Winner?
LeMaitre Vascular Inc (NASDAQ:LMAT), a global provider of disposable and implantable vascular devices, recently made an acquisition of privately-owned Clinical Instruments.
BIOLASE Inc (BIOL) Shareholders: Have You Seen This Crucial Data?
BIOLASE Inc (NASDAQ:BIOL) was in 4 hedge funds' portfolio at the end of the fourth quarter of 2012.
